Abstract:Objective: To review the clinical details and further treatments for recurrent spinal giant cell tumors (SGCT), and to analyze the risk factors of recurrence and shed new light on the treatment options and prognosis of recurrent SGCT. Methods: A retrospective analysis of recurrent SGCT between April 2003 and January 2014 was performed. A total of 10 patients comprising 3 men and 7 women with a mean age of 28.9 years (range, 21-40 years) were included in the study. All complete clinical data, radiographs, CT, MRI, scans and pathological data were reviewed. The tumor locations and the regions involved were evaluated by CT and MRI. The blood supply of the tumors was evaluated by enhanced CT and MRI. The mean follow-up was 81.3 months (range, 35.7-172.1 months). Results: All patients had Enneking stage 3 tumors; 9 (90%) of them had different extents of spinal canal involvement in the primary time period. All patients underwent intralesional resection during their first surgery. Only 1 patient received local adjuvant treatments; no patient underwent selective arterial embolization or used denosumab at that time. Only 1 patient underwent adjuvant radiotherapy postoperatively, and another patient used bisphosphonates. After recurrence, 1 patient was cured using denosumab, and 2 patients' disease was controlled through use of other medical treatments or adjuvant treatments. There were 3 repeated recurrences and 7 repeated surgical procedures were performed in 5 patients. There were 6 intralesional excisions and 1 decompression surgery. The mean relapse-free time after the first surgery was 32.3 months (range, 10.5-62.6 months). The overall mean relapse-free time was 40.2 months (range, 10.5-157 months). No distant metastasis was found in our series. At the final follow-up, 4 patients were disease free, 3 patients' disease was under control, 2 has progressive disease aggravation, while 1 patient died as a result of progression of disease 133.9 months after first surgery. Conclusion: Intralesional excision for recurrent spinal giant cell tumors is an effective option that may have satisfactory prognosis. However, the excision and the inactivation of the lesion should be carried out carefully and thoroughly without missing any corners. Early diagnosis of recurrence may be associated with better prognosis. Adjuvant treatments perioperatively and systemic medical treatments can decrease recurrence rates and can have therapeutic effects in the recurrent SGCT.

Surgical Outcomes in Spinal Cord Subependymomas: an Institutional Experience.

Diagnosis and Treatment of Subependymoma in Spinal Cord

Diagnosis and microsurgical treatment of spinal cord subependymoma

Surgical Treatment of 660 Consecutive Cases of Spinal Cord Tumor

Surgical Strategies and Outcomes of Spinal Ependymomas of Different Lengths: Analysis of 210 Patients

Clinical Characteristics and Surgical Outcomes of Spinal Intramedullary Ependymal Cysts

Treatment strategies and efficacy analysis of intramedullary spinal cord ependymoma

Recurrence of Giant Cell Tumor of the Spine after Resection: A Report of 10 Cases.

Surgical Outcomes Of Spinal Cord Intramedullary Cavernous Malformation: A Retrospective Study Of 83 Patients In A Single Center Over A 12-Year Period

Surgical Management of Intramedullary Spinal Cord Tumors: Surgical Resection and Prognosis

Spinal meningiomas: Treatment outcome and long-term follow-up

Characteristic and Surgical Results of Multisegment Intramedullary Cervical Spinal Cord Tumors

Diagnosis and treatment of subependymomas of the lateral ventricles

Microsurgery of Intramedullary Spinal Cord Tumor

Long-Term Functional Outcomes Following Surgical Treatment of Spinal Schwannomas: A Population-Based Cohort Study

Long-term postoperative outcomes of spinal cellular schwannoma: study of 93 consecutive cases

Spinal Intradural Tumor Resection via Long-Segment Approaches and Clinical Long-Term Follow-Up

Surgical Treatment for Intramedullary Spinal Cord Tumors:56 Cases Experience

Intramedullary Subependymoma Of Lower Thoracic Cord

Outcomes in treatment for primary spinal anaplastic ependymomas: A retrospective series of 20 patients

Surgical Outcomes of Clival Chordoma Through Endoscopic Endonasal Approach: A Single-Center Experience